City

Bethesda (2)

Condition

Membranous Glomerulonephritis (2)

Autoimmune Disease (1)

Glomerular Disease (1)

Lupus Membranous Nepropathy (1)

Nephrotic Syndrome (1)

Proteinuria (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)

Collaborator

Intervention

oral cyclosporine (1)

rituximab infusion (1)

sirolimus (1)

Study Documents

Intervention Type

drug (2)

Funder Type

NIH (2)

Study Type

Interventional (2)

membranous glomerulonephritis

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Nephrotic Syndrome, Proteinuria, Autoimmune Disease Trial run by the NIDDK (Rituximab Infusion, Oral Cyclosporine)

Recruiting

Nephrotic Syndrome
+4 more

Rituximab Infusion
Oral Cyclosporine

Bethesda, Maryland
+1 more

Jan 25, 2023

Membranous Glomerulonephritis, Lupus Membranous Nepropathy Trial run by the NIDDK (Sirolimus)

Completed

Membranous Glomerulonephritis
Lupus Membranous Nepropathy

Sirolimus

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Oct 5, 2017